Marc R. Tremblay is president of the clinical diagnostics division of Thermo Fisher Scientific. He is responsible for driving innovation and growth in the company’s clinical chemistry analyzers and reagents, automation solutions, biomarkers and niche diagnostics businesses. Prior to his current role, Tremblay was vice president and general manager of the company’s portable elemental and molecular analyzer business. Before joining Thermo Fisher in 2009, Tremblay held a number of executive management positions, including senior vice president at DigitalGlobe, vice president at Z Corporation, president and CEO at Syncline and vice president at Virtual Technologies. Tremblay sits on the advisory boards of Skybox Imaging and American Innovative. Tremblay earned his doctorate from Stanford University and his master’s degree in business administration from Harvard University.